Keith Bragman
Directeur/Membre du Conseil chez Faculty of Pharmaceutical Medicine
Postes actifs de Keith Bragman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Faculty of Pharmaceutical Medicine | Directeur/Membre du Conseil | 04/03/2010 | - |
Historique de carrière de Keith Bragman
Anciens postes connus de Keith Bragman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Directeur/Membre du Conseil | 04/03/2010 | 10/05/2011 |
ClinPhone Plc
ClinPhone Plc Packaged SoftwareTechnology Services The Group's principal activity is the provision of technology solutions to the clinical trials industry. The Group's technology, services and products provide its customers, typically pharmaceutical and biotechnology companies, collects data and arrange clinical trials. These includes a range of consultancy, services and software. The Group's products includes ClinPhone Patient Recruitment, ClinPhone Randomisation, ClinPhone Trial Supply Management, ClinPhone ePRO, ClinPhone Clinical Trials Management Software, ClinPhone Drug Accountability, ClinPhone Integration Services and ClinPhone Trial Supply Simulation. | Directeur/Membre du Conseil | - | 12/08/2009 |
Bristol-Myers Squibb International Corp. | Corporate Officer/Principal | - | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - | - |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | - | - |
UCB | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - | |
INNATE PHARMA | Directeur/Membre du Conseil | 04/03/2010 | - |
Statistiques
Internationale
Etats-Unis | 4 |
Royaume-Uni | 3 |
Belgique | 3 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 4 |
Sectorielle
Health Technology | 5 |
Technology Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
INNATE PHARMA | Health Technology |
UCB | Health Technology |
Entreprise privées | 6 |
---|---|
ClinPhone Plc
ClinPhone Plc Packaged SoftwareTechnology Services The Group's principal activity is the provision of technology solutions to the clinical trials industry. The Group's technology, services and products provide its customers, typically pharmaceutical and biotechnology companies, collects data and arrange clinical trials. These includes a range of consultancy, services and software. The Group's products includes ClinPhone Patient Recruitment, ClinPhone Randomisation, ClinPhone Trial Supply Management, ClinPhone ePRO, ClinPhone Clinical Trials Management Software, ClinPhone Drug Accountability, ClinPhone Integration Services and ClinPhone Trial Supply Simulation. | Technology Services |
Faculty of Pharmaceutical Medicine | |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Bristol-Myers Squibb International Corp. |
- Bourse
- Insiders
- Keith Bragman
- Expérience